Skip to main content
The Egyptian Journal of Internal Medicine

Table 3 Comparison and post hoc analysis between control, DM, DN, and DM with cardiovascular disease regarding serum irisin

From: Association between irisin and vascular complications of type 2 diabetic patients: a prospective case–control study

 

Control group

All patients

DM only

Diabetic nephropathy

DM + cardiovascular

p-value

No. 30

No. 60

No. 20

No. 20

No. 20

Serum irisin (ng/dl0)

Mean ± SD

1.39 ± 0.90

1.02 ± 0.28

1.06 ± 0.27

0.94 ± 0.17

1.05 ± 0.36

0.039

 

Post hoc analysis

 

P1

P2

P3

P4

P5

P6

P7

Serum irisin

0.005

0.057

0.009

0.041

0.532

0.942

0.570

  1. Data are presented by mean ± standard deviation (SD). P-value > 0.05, nonsignificant; P-value < 0.05, significant; P-value < 0.01, highly significant. P1, control vs all patients; P2, control vs DM only; P3, control vs DN; P4, control vs DM + cardiovascular; P5, DM vs DN; P6, DM vs DM + cardiovascular; P7, DN vs DM + cardiovascular
Back to article page